Hematology/Oncology

Top Story

Senate approves $1.1b in Zika funding as part of stopgap spending bill

September 28, 2016

The Senate on Wednesday passed a bill to keep the federal government running through Dec. 9, including $1.1 billion in long-awaited emergency funding for prevention and treatment of the Zika virus, according to reports.

The 72-26 vote came just 2 days before federal agencies were set to run out of money, and represents a break in the months-long stalemate over the issue of funding a response to the Zika virus, which has been confirmed to cause microcephaly and other birth defects. The bill also provides $37 million to fight opioid addiction, and includes funding to provide assistance to Flint, Michigan, to address the lead in its water supply.

Meeting News Coverage

IMRT reduces toxicity, improves quality of life in women with cervical, endometrial cancers

September 28, 2016
Women with cervical or endometrial cancers who underwent pelvic intensity-modulated radiation therapy reported fewer acute genitourinary and gastrointestinal toxicities…
At Issue

Tyrosine kinase inhibitors lead to ‘dramatic’ improvements in CML

September 28, 2016
The development of tyrosine kinase inhibitors for chronic myeloid leukemia, including imatinib, was spurred by an increased understanding of the disease’s…
Meeting News CoveragePerspective

Late toxicity comparable between extremely hypofractionated, conventional radiotherapy for prostate cancer

September 28, 2016
Treatment with extremely hypofractionated radiotherapy resulted in similar adverse events after 2 years as conventionally fractionated radiotherapy for men with…
Meeting News CoveragePerspective

Hypofractionated radiation therapy offers shorter treatment for poor-performance NSCLC

September 28, 2016
The use of accelerated hypofractionated radiation therapy produced equivalent OS and PFS outcomes as conventional radiation therapy in patients with non–small cell…
More News Headlines »
CME

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

This activity is supported by an educational grant from Genentech.

Melanoma is the deadliest form of skin cancer. Historically, treatment options have been limited for patients with…
More »
Video
Meeting News Coverage

VIDEO: Crenolanib, venetoclax demonstrate ‘very exciting’ results in AML

August 21, 2016
More »
Featured
At Issue: Breast Cancer Resource Center

At Issue: Breast Cancer Resource Center

CME

Updates from Vienna 2015 – Highlights in Hematologic Malignancies

This activity is supported by an educational grant from Genentech, Inc.

The management of patients with hematologic malignancies—from diagnosis to treatment decisions—can represent a…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan
morganatic-roan